Credo (CRDO) CEO Reports 68,016-Share Sale; 10b5-1 Plan Used
Rhea-AI Filing Summary
Credo Technology Group Holding Ltd (CRDO) insider sale summary: On 09/16/2025 William J. Brennan, who is President, CEO and a director, reported multiple open-market sales totaling 68,016 ordinary shares. The sales were executed in tranches at weighted-average prices ranging from about $160.80 to $167.78 per share and were effected under a Rule 10b5-1 trading plan adopted April 15, 2025. After the transactions, the reporting person directly owned 369,173 shares and indirectly (through The Brennan Family Trust dated 09/06/2002) had beneficial ownership of 1,992,502 shares, with the reporting person disclaiming beneficial ownership except to the extent of pecuniary interest.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating transactions were pre-arranged
- Detailed price ranges and weighted-average prices provided for each tranche
- Reporting retains substantial ongoing ownership (approximately 2.36 million shares combined)
Negative
- Insider sold 68,016 shares on 09/16/2025, which is a notable single-day disposition
- Significant portion of holdings placed into market across multiple tranches, which could be interpreted negatively by some investors
Insights
TL;DR: Insider sold 68,016 shares under a pre-established 10b5-1 plan; holdings remain substantial, suggesting routine liquidity rather than full exit.
The disclosed trades were executed in multiple tranches on 09/16/2025 at weighted-average prices spanning roughly $160.80 to $167.78. Total shares sold equal 68,016, which reduced direct and indirect holdings but left the reporting person with material exposure: approximately 2.36 million shares combined between direct and trust holdings. The use of a 10b5-1 plan and the detailed price ranges provided in the explanations are consistent with pre-planned, rule-compliant disposition rather than opportunistic intra-period selling. From a quantitative standpoint, the sales represent a modest percentage of total reported holdings and therefore are unlikely, by themselves, to be materially dilutive or indicate a change in control.
TL;DR: Disclosure is thorough and includes 10b5-1 plan citation and price ranges; beneficial ownership disclaimers are stated.
The Form 4 clearly states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted April 15, 2025, and provides weighted-average prices and price ranges for each tranche. The Reporting Person disclaims beneficial ownership of the trust-held shares except for pecuniary interest, which is properly noted. Signature by an attorney-in-fact is included. These elements meet standard corporate governance disclosure expectations for insider dispositions. No flags for incomplete procedural disclosure are present in the filing itself.